Division of Pediatrics

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Osteosarcoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Ewing's Sarcoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Precursor Cell Lymphoblastic Leukemia-Lymphoma Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

Photo of Martha Askins

Martha Askins

Person: Academic

19892018
No photo of Izhar Singh Batth

Izhar Singh Batth

Person: Academic

20152018
Photo of Joya Chandra

Joya Chandra

Person: Academic

19962018

Research Output 1955 2019

1 Citation (Scopus)

Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and Braf V600E -Induced Tumorigenesis

Tao, Y., Kang, B., Petkovich, D. A., Bhandari, Y. R., In, J., Stein-O'Brien, G., Kong, X., Xie, W., Zachos, N., Maegawa, S., Vaidya, H., Brown, S., Chiu Yen, R. W., Shao, X., Thakor, J., Lu, Z., Cai, Y., Zhang, Y., Mallona, I., Peinado, M. A. & 6 othersZahnow, C. A., Ahuja, N., Fertig, E., Issa, J. P., Baylin, S. B. & Easwaran, H., Feb 11 2019, In : Cancer Cell. 35, 2, p. 315-328.e6

Research output: Contribution to journal › Article

Epigenomics
Organoids
Colon
Carcinogenesis
Clustered Regularly Interspaced Short Palindromic Repeats
3 Citations (Scopus)

A Phase 1/2 Trial of Reirradiation for Diffuse Intrinsic Pontine Glioma

Amsbaugh, M. J., Mahajan, A., Thall, P. F., McAleer, M. F., Paulino, A. D. C., Grosshans, D. R., Khatua, S., Ketonen, L., Fontanilla, H. & McGovern, S. L., May 1 2019, In : International Journal of Radiation Oncology Biology Physics. 104, 1, p. 144-148 5 p.

Research output: Contribution to journal › Article

Glioma
dosage
toxicity
progressions
Disease-Free Survival

A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group

Isakoff, M. S., Goldsby, R., Villaluna, D., Krailo, M. D., Hingorani, P., Collier, A., Morris, C. D., Kolb, E. A., Doski, J. J., Womer, R. B., Gorlick, R. & Janeway, K. A., Feb 1 2019, In : Pediatric Blood and Cancer. 66, 2, e27524.

Research output: Contribution to journal › Article

eribulin
Osteosarcoma